7773-01-5

• 常用中文名：氯化锰
• 常用英文名：Manganese chloride
• CAS号：7773-01-5
• 分子式：Cl₂Mn
• 分子量：125.84400
• 相关类别： 无机化工 无机盐 金属卤化物及卤酸盐 金属氯化物及盐
• 发布时间：2018-03-13 08:00:00
• 更新时间：2026-06-30 12:56:16
• 【用途一】
  用于铝合金冶炼、有机氯化物触媒、染料和颜料的制造，以及用于制药和干电池等
  【用途二】
  营养增补剂(锰强化剂)。
  【用途三】
  用作有机物氯化催化剂，油漆催干剂和汽油抗震剂原料。用于饲料辅助剂、分析试剂、染料和颜料制造。镁合金、铝合金冶炼，棕黑色砖瓦生产以及制药和干电池制造。在农业上还用作微量元素肥料。

名称

• 中文名: 氯化锰
• 英文名: manganese(II) chloride
• 中文别名: 无水二氯化锰; 无水氯化锰(II)(-MN)PURATREM; 氯化锰缓冲液(PCR级); 无水氯化锰(II), ANHYDROUS; 超干氯化锰(II), ULTRA DRY; 超干氯化锰; 无水超干氯化锰; 锰标准浓缩液 10.00G MN; 氯化锰(II),超干; 无水氯化锰(II); MANGANESE CHLORIDE 无水氯化锰; 氯化锰(II); 氯化锰缓冲液(PCR级) 7-5; 氯化锰,无水; 二氯化锰(II) 溶液; 二氯化锰四水合物; 二氯化锰(II); 无水氯化锰; MALT EXTRACT POWDER 麦芽浸粉; 锰原子光谱分析标准浓缩液 1.00G MN; 氯化锰（无水）; 氨化锰; 氯化锰(二氯化锰); 二氯化锰; 无水氯化锰(II),ANHYDROUS; 氯化锰，无水; 氯化亚锰; 食品级氯化锰; 氯化锰,四水; 无水氯化锰,二氯化锰; 耐磨地坪颜料 耐磨地坪绿 金刚砂地坪绿; 氯化亚锰,二氯化锰; 氯化锰(无水) 7773; 氯化锰(II) BEADS
• 英文别名: MANGANESE ATOMIC SPECTROSCOPY STD. CONC. 10. AMPOULE; manganese:dichloride; MFCD00011114; Manganese(II) chloride, anhydrous, 80 mesh; Manganese bister; Dichloromanganese(II); Manganese(II) chloride anhydrous (-Mn) PURATREM; MANGANESE ATOMIC SPECTROSCOPY STD. CONC. 1. AMPOULE; MANGANESE CHLORIDE, ANHYDROUS, BEADSMANGANESE CHLORIDE, ANHYDROUS, BEADSMANGANESE CHLORIDE, ANHYDROUS, BEADS; anese(II) chL; Manganese(II) chloride 0.1 M Solution; Manganese(II) chloride, anhydrous, 80 Mesh, R; manganese standd concentrate 10. mn; manganese(ii) chloride solution; MANGANESE CHLORIDE ANHYDROUS, BEADS; MANGANESE (II) CHLORIDE, ULTRA DRY; MANGANESE(II) CHLORIDE, ANHYDROUS, BEADS , -10 MESH; scacchite; Manganese(II)chloride,ultradry; MANGANESE(II) CHLORIDE, BEADS; Manganese(II) chloride, anhydrous, ampuled under gon, trace; MANGANESE CHLORIDE ANHYDROUS; Manganese bichloride; MANGANESE CHLORIDE; MANGANESE DICHLORIDE; MANGANESE CHLORIDE 4N; MANGANESE CHLORIDE ANHYDROUS, POWDER; manganese(ii)chloride(1:2); manganese atomic spectroscopy standd concentrate 1. mn; EINECS 231-869-6; Manganese(II) chloride (1:2); Sacchite; Manganese Chloride (AS); Manganese atomic spectroscopy standd concentrate 10. Mn; Manganese(II) dichloride; Manganese(II) chloride anhydrous crystalline (Assay, metal basis); MANGANESE(II) CHLORIDE, FLAKES; di-manganesechlorid; Manganese(II) chloride anhydrous, beads, -10 Mesh, trace Metals basis; MANGANESE CHLORIDE MIN; MANGANOUS CHLORIDE; Manganese cllloride; Additive Screening Solution 26/Fluka kit no; manganese(ii)chloride solution; MANGANESE (II) CHLORIDE ANHYDROUS; MANGANESE(II) CHLORIDE; Manganese(II)chloride,anhydrous; manganese(ii) chloride, ultra dry; Manganese(II) chloride,anhydrous, 80 mesh; Manganese(II) chloride powder and chunks, >= trace Metals basis

物化性质

• 密度: 2.98 g/mL at 25 °C(lit.)
• 沸点: 1190 °C
• 熔点: 652 °C(lit.)
• 分子式: Cl₂Mn
• 分子量: 125.84400
• 闪点: 1190°C
• 精确质量: 124.87600
• 外观性状: 粉红色粉末
• 储存条件:

  本品非易燃易爆物品。应贮存于阴凉、通风、干燥的库房中，密封保存，按一般化学品运输，防雨淋和日光暴晒。

• 稳定性:

  1.避免接触还原剂，酸，碱金属。有潮解性。在100g水中的溶解度为77.2g(25℃)、112.7g(80℃)。溶于乙醇，不溶于乙醚。

  2.有吸水性，易潮解。在106℃时失去一分子结晶水，在200℃则失去全部结晶水而成无水物。在空气中加热无水物，则分解而放出HCl，生成Mn3O4。在室温下易溶于水，极易溶于热水。溶于乙醇，不溶于乙醚。

  3.锰有毒，可造成中枢神经系统的损伤，有时出现胃部变化和多发性神经炎；之后出现初期中毒性脑病；后期为帕金森症，特点是：面部呆板、无力、情绪冷淡、语言障碍等。对皮肤有损伤，可造成皮炎、慢性湿疹。使皮肤上抓伤不易愈合，淋巴腺也普遍肿大。

• 水溶解性: 723 g/L (25 ºC)
• 分子结构:

  1、摩尔折射率：无可用的

  2、摩尔体积（cm³/mol）：无可用的

  3、等张比容（90.2K）：无可用的

  4、表面张力（dyne/cm）：无可用的

  5、介电常数：无可用的

  6、极化率（10^-24cm³）：无可用的

  7、单一同位素质量：124.875754 Da

  8、标称质量：125 Da

  9、平均质量：125.844 Da

• 更多:

  1. 性状：红玫瑰色的叶状结晶。有潮解性

  2. 密度（g/mL 25ºC）：2.97

  3. 相对蒸汽密度（g/mL,空气=1）：未确定

  4. 熔点（ºC）：650

  5. 沸点（ºC，常压）：1190

  6. 沸点（ºC,5.2kPa）：未确定

  7. 折射率（n20/D）：未确定

  8. 闪点（ºC，）：1190

  9. 比旋光度（º）：未确定

  10. 自燃点或引燃温度（ºC）：未确定

  11. 蒸气压（kPa,25ºC）：未确定

  12. 饱和蒸气压（kPa,60ºC）：未确定

  13. 燃烧热（KJ/mol）：未确定

  14. 临界温度（ºC）：未确定

  15. 临界压力（KPa）：未确定

  16. 油水（辛醇/水）分配系数的对数值（25℃）：未确定

  17. 爆炸上限（%,V/V）：未确定

  18. 爆炸下限（%,V/V）：未确定

  19. 溶解性(mg/mL)：易溶于水，溶于醇，不溶于醚

MSDS

第一部分：化学品名称 化学品中文名称: 氯化锰；二氯化锰 化学品英文名称: Manganese chloride；Manganese dichloride CAS No.: 7773-01-5 分子式: MnCl2 分子量: 125.84 第二部分：成分/组成信息 化学品名称：氯化锰；二氯化锰 有害物成分: 氯化锰 含量: 100 CAS No.: 7773-01-5 第三部分：危险性概述 侵入途径: 吸入 食入 健康危害: 个别人吸入高浓度氯化锰，可引起呼吸困难，甚至意识模糊。轻者头痛、咳嗽；重者严重兴奋、易怒、幻觉和妄想，有强迫行为和情绪不稳等表现。若发生慢性中毒，初期表现为神经衰弱综合征和植物神经功能障碍，继续发展可出现明显锥体外系损害为主的神经体征。 环境危害: 对环境有危害，对水体可造成污染。 燃爆危险: 本品不燃。 第四部分：急救措施 皮肤接触: 用肥皂水及清水彻底冲洗。就医。 眼睛接触: 拉开眼睑，用流动清水冲洗15分钟。就医。 吸入: 脱离现场至空气新鲜处。就医。 食入: 误服者，口服牛奶、豆浆或蛋清，就医。 第五部分：消防措施 危险特性: 与钠、钾发生剧烈反应。与锌箔加热时发生爆炸性反应。受高热分解，放出有毒的烟气。 有害燃烧产物: 氯化氢。 灭火方法及灭火剂: 在上风向灭火。灭火时尽可能将容器从火场移至空旷处。然后根据着火原因选择适当灭火剂灭火。 消防员的个体防护: 消防人员必须穿全身防火防毒服 第六部分：泄漏应急处理 应急处理: 隔离泄漏污染区，周围设警告标志，建议应急处理人员戴自给式呼吸器，穿化学防护服。小心扫起，避免扬尘，运至废物处理场所。用水刷洗泄漏污染区，经稀释的污水放入废水系统。如大量泄漏，收集回收或无害处理后废弃。 第七部分：操作处置与储存 操作注意事项: 密闭操作，提供充分的局部排风。防止粉尘释放到车间空气中。操作人员必须经过专门培训，严格遵守操作规程。建议操作人员佩戴防尘面具（全面罩），穿橡胶耐酸碱服，戴橡胶耐酸碱手套。避免产生粉尘。避免与酸类、钾、钠、锌接触。配备泄漏应急处理设备。倒空的容器可能残留有害物。 储存注意事项: 储存于阴凉、通风的库房。远离火种、热源。防止阳光直射。包装必须密封，切勿受潮。应与酸类、钾、钠、锌等分开存放，切忌混储。储区应备有合适的材料收容泄漏物。 第八部分：接触控制/个体防护 最高容许浓度: 中 国 MAC：0．2mg(MnO2)／m3 前苏联MAC：未制订标准美国TLV—TWA： 工程控制: 密闭操作，局部排风。 呼吸系统防护: 可能接触其蒸气时，必须佩戴防毒口罩。紧急事态抢救或逃生时，佩戴自给式呼吸器。 眼睛防护: 戴化学安全防护眼镜。 身体防护: 穿相应的防护服。 手防护: 戴防化学品手套。 其他防护: 工作现场禁止吸烟、进食和饮水。工作后，淋浴更衣。注意个人清洁卫生。 第九部分：理化特性 外观与性状: 玫瑰色立方形晶体，微有潮解性。 熔点(℃): 650 沸点(℃): 1190 相对密度(水=1): 2．977(25／4℃) 分子式: MnCl2 分子量: 125.84 溶解性: 溶于水、醇，不溶于醚。 主要用途: 用于制油漆催干剂，并用作催化剂和分析试剂。 第十部分：稳定性和反应活性 稳定性: 在常温常压下 稳定 禁配物: 强酸、潮湿空气、钾、钠、锌。 聚合危害: 不能出现 分解产物: 氯化氢。 第十一部分：毒理学资料 急性毒性: LD50：1715mg／kg(小鼠经口) LC50： 第十三部分：废弃处置 废弃处置方法: 用安全掩埋法处置。在能利用的地方重复使用容器或在规定场所掩埋。 第十四部分：运输信息 运输注意事项: 起运时包装要完整，装载应稳妥。运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与酸类、活性金属、活性金属、金属粉末等混装混运。运输途中应防曝晒、雨淋，防高温。 第十五部分：法规信息 国内化学品安全管理法规: 化学危险物品安全管理条例 (1987年2月17日国务院发布)，化学危险物品安全管理条例实施细则 (化劳发[1992] 677号)，工作场所安全使用化学品规定 ([1996]劳部发423号)等法规，针对化学危险品的安全使用、生产、储存、运输、装卸等方面均作了相应规定。 第十六部分：其他信息 参考文献: 1.周国泰，化学危险品安全技术全书，化学工业出版社，1997 2.国家环保局有毒化学品管理办公室、北京化工研究院合编，化学品毒性法规环境数据手册，中国环境科学出版社.1992 3.Canadian Centre for Occupational Health and Safety,CHEMINFO Database.1998 4.Canadian Centre for Occupational Health and Safety, RTECS Database, 1989 填表时间: 年月日 其他信息: 5 MSDS修改日期: 年月日

毒性和生态

毒理学数据: 1、急性毒性：LD50：1715 mg/kg(小鼠经口) 生态学数据: 对水是稍微危害的，若无政府许可，勿将材料排入周围环境。 CHEMICAL IDENTIFICATION RTECS NUMBER : OO9625000 CAS REGISTRY NUMBER : 7773-01-5 LAST UPDATED : 199806 DATA ITEMS CITED : 86 MOLECULAR FORMULA : Cl2-Mn MOLECULAR WEIGHT : 125.84 WISWESSER LINE NOTATION : MN G2 HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 250 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 147 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 92600 ug/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - convulsions or effect on seizure threshold TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 700 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 1031 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 121 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 210 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 38 mg/kg TOXIC EFFECTS : Behavioral - somnolence (general depressed activity) Behavioral - ataxia Lungs, Thorax, or Respiration - respiratory stimulation TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intramuscular SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 255 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 202 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Parenteral SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 128 mg/kg TOXIC EFFECTS : Cardiac - other changes Vascular - BP lowering not characterized in autonomic section Gastrointestinal - other changes TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 600 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Mammal - cat DOSE/DURATION : 4 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 180 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 64800 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Parenteral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 41 mg/kg TOXIC EFFECTS : Cardiac - other changes Vascular - BP lowering not characterized in autonomic section Gastrointestinal - other changes TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 6500 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 916 mg/kg TOXIC EFFECTS : Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 180 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 60 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 1240 mg/kg/7D-I TOXIC EFFECTS : Brain and Coverings - other degenerative changes Biochemical - Effect on specific coenzyme - not otherwise specified Biochemical - Neurotransmitters or modulators (putative) - dopamine in striatum TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2520 mg/kg/3W-C TOXIC EFFECTS : Brain and Coverings - other degenerative changes Vascular - BP lowering not characterized in autonomic section Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other Enzymes TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2405 mg/kg/30D-C TOXIC EFFECTS : Liver - other changes Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 245 gm/kg/35W-C TOXIC EFFECTS : Brain and Coverings - other degenerative changes Nutritional and Gross Metabolic - changes in metals, not otherwise specified Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - other oxidoreductases TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 630 mg/kg/6W-I TOXIC EFFECTS : Brain and Coverings - other degenerative changes Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical - Metabolism (Intermediary) - other TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 271 gm/kg/1Y-C TOXIC EFFECTS : Brain and Coverings - other degenerative changes Nutritional and Gross Metabolic - weight loss or decreased weight gain TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 280 mg/kg/4W-I TOXIC EFFECTS : Liver - changes in liver weight Endocrine - changes in spleen weight Immunological Including Allergic - decrease in humoral immune response TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rabbit DOSE/DURATION : 6 gm/kg/60D-I TOXIC EFFECTS : Related to Chronic Data - death TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - guinea pig DOSE/DURATION : 300 mg/kg/30D-I TOXIC EFFECTS : Gastrointestinal - alteration in gastric secretion Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 2080 mg/kg/26W-I TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Blood - lymphoma, including Hodgkin's disease TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 2080 mg/kg/26W-I TOXIC EFFECTS : Tumorigenic - Carcinogenic by RTECS criteria Blood - lymphoma, including Hodgkin's disease TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 106 mg/kg SEX/DURATION : female 30 week(s) pre-mating TOXIC EFFECTS : Reproductive - Fertility - pre-implantation mortality (e.g. reduction in number of implants per female; total number of implants per corpora lutea) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 148 gm/kg SEX/DURATION : female 1-22 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 72420 mg/kg SEX/DURATION : female 1-22 day(s) after conception lactating female 30 day(s) post-birth TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous DOSE : 9060 ug/kg SEX/DURATION : female 6-17 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous DOSE : 45302 ug/kg SEX/DURATION : female 6-17 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - musculoskeletal system TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intratesticular DOSE : 10067 ug/kg SEX/DURATION : male 1 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - testes, epididymis, sperm duct TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous DOSE : 10067 ug/kg SEX/DURATION : male 30 day(s) pre-mating TOXIC EFFECTS : Reproductive - Paternal Effects - testes, epididymis, sperm duct TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intraperitoneal DOSE : 4581 mg/kg SEX/DURATION : female 12-16 week(s) after conception TOXIC EFFECTS : Reproductive - Specific Developmental Abnormalities - blood and lymphatic systems (including spleen and marrow) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous DOSE : 30 mg/kg SEX/DURATION : female 8 day(s) after conception TOXIC EFFECTS : Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) TYPE OF TEST : Specific locus test TYPE OF TEST : Sex chromosome loss and nondisjunction TYPE OF TEST : Dominant lethal test MUTATION DATA TYPE OF TEST : DNA damage TEST SYSTEM : Mammal - species unspecified Lymphocyte DOSE/DURATION : 5 mmol/L REFERENCE : SCIEAS Science. (American Assoc. for the Advancement of Science, 1333 H St., NW, Washington, DC 20005) V.1- 1895- Volume(issue)/page/year: 198,513,1977 *** REVIEWS *** ACGIH TLV-TWA 0.2 mg(Mn)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW AMRL** Aerospace Medical Research Laboratory Report. (Aerospace Technical Div., Air Force Systems Command, Wright-Patterson Air Force Base, OH 45433) Volume(issue)/page/year: TR-73-125,1973 TOXICOLOGY REVIEW ADTEAS Advances in Teratology. (New York, NY) V.1-5, 1966-72. Discontinued. Volume(issue)/page/year: 5,51,1972 TOXICOLOGY REVIEW 85DHAX "Medical and Biologic Effects of Environmental Pollutants Series," Washington, DC, National Academy of Sciences, 1972-77 Volume(issue)/page/year: Mn,121,1973 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:CL 5 mg(Mn)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,149,1971 OSHA PEL (Gen Indu):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):CL 5 mg(Mn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 5 mg(Mn)/m3 JAN 1993 OEL-BELGIUM:TWA 5 mg(Mn)/m3 JAN 1993 OEL-DENMARK:TWA 2.5 mg(Mn)/m3 JAN 1993 OEL-FINLAND:TWA 2.5 mg(Mn)/m3 JAN 1993 OEL-HUNGARY:TWA 0.3 mg(Mn)/m3;STEL 0.6 mg(Mn)/m3 JAN 1993 OEL-JAPAN:TWA 0.3 mg(Mn)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 1 mg(Mn)/m3 JAN 1993 OEL-POLAND:TWA 0.3 mg(Mn)/m3 JAN 1993 OEL-SWEDEN:TWA 1 mg(Mn)/m3;STEL 2.5 mg(Mn)/m3 (resp. dust) JAN 1993 OEL-SWEDEN:TWA 2.5 mg(Mn)/m3;STEL 5 mg(Mn)/m3 (total dust) JAN 1993 OEL-UNITED KINGDOM:TWA 5 mg(Mn)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84353 No. of Facilities: 320 (estimated) No. of Industries: 7 No. of Occupations: 12 No. of Employees: 4916 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84353 No. of Facilities: 788 (estimated) No. of Industries: 6 No. of Occupations: 16 No. of Employees: 13961 (estimated) No. of Female Employees: 9451 (estimated)

安全

• 符号: GHS05, GHS08
• 信号词: Danger
• 危害声明: H318-H373-H412
• 警示性声明: P273-P280-P305 + P351 + P338 + P310
• 靶器官: Brain
• 个人防护装备: Eyeshields;Faceshields;Gloves;half-mask respirator (US);multi-purpose combination respirator cartridge (US)
• 危害码 (欧洲): Xn:Harmful
• 风险声明 (欧洲): R22;R48/22;R52
• 安全声明 (欧洲): S45-S61-S22-S36
• 危险品运输编码: UN 3288 6.1/PG 3
• WGK德国: 1
• RTECS号: OO9625000
• 海关编码: 2827399000

制备

1.开始时，在常温下将碳酸锰置于氯化氢气流中，直至不再产生二氧化碳。接着，在继续通氯化氢的同时，加热至暗红热状态。再在红热状态下熔融，经放置即析出MnCl2结晶。

2.取乙酸锰4g，加入装有分液漏斗的玻璃容器中，再加入苯15mL，用磁力搅拌器充分搅拌，并从分液漏斗慢慢滴入超过计算量10%的乙酰氯CH3COCl，充分搅拌30min后，生成二氯化锰的沉淀，过滤，除去母液，再加入与前面等量的乙酰氯，煮沸5min，用苯洗涤3次，每次用20mL。最后置氮气流中于200℃下加热3h。

3.菱锰矿  盐酸法　经粉碎的菱锰矿在反应器中与过量的盐酸反应完全后，加入石灰中和过量的盐酸，控制ph值为4左右，加入过氧化氢除去铁。然后在溶液中加入硫酸锰除去钙，净化后的溶液经蒸发、过滤、再蒸发浓缩、冷却结晶、离心分离，制得氯化锰成品。其反应式如下：

4.软锰矿  盐酸法　将软锰矿与煤粉混合，还原焙烧生成一氧化锰，或锰矿直接与盐酸反应，经过滤除杂、浓缩、冷却结晶、离心分离，制得氯化锰成品。其反应式如下：

海关

海关编码	2827399000